Q-omics provides the consensus-scored MTATP8P1 profile across patient tissues and cancer cell-line models. MTATP8P1 expression is associated with patient survival in 24 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, MTATP8P1 is differentially expressed in 7, with the highest sampling consensus in KIRC. Additionally, MTATP8P1 RNA expression shows 16,253 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight ACC, and KIRC as cancer lineages where MTATP8P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MTATP8P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MTATP8P1 survival associations across molecular data types. MTATP8P1 RNA expression shows survival associations in the most cancer types (24). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MTATP8P1 RNA expression–survival associations across cancer types. High MTATP8P1 expression shows unfavorable associations in UCEC, but favorable associations in ACC, KIRC, LIHC, CESC and KIRP. The ACC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for MTATP8P1 RNA expression.
This table summarizes MTATP8P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for MTATP8P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MTATP8P1 shows lower tumor expression in KIRC, LIHC, CHOL, BRCA and PAAD and higher tumor expression in KICH. The KIRC box plot shows higher MTATP8P1 RNA expression in normal versus tumor tissue (log2 FC = −0.895, t-test p < 0.001).
This table shows molecular features associated with MTATP8P1 in patient tissues and cancer cell lines. In patient samples, MTATP8P1 shows the broadest associations at the RNA and protein expression levels, with ACC recurring as the lineage with the largest associated feature set.
